NAD+ analog reveals PARP-1 substrate-blocking mechanism and allosteric communication from catalytic center to DNA-binding domains

PARP-1 cleaves NAD+ and transfers the resulting ADP-ribose moiety onto target proteins and onto subsequent polymers of ADP-ribose. An allosteric network connects PARP-1 multi-domain detection of DNA damage to catalytic domain structural changes that relieve catalytic autoinhibition; however, the mechanism of autoinhibition is undefined. Here, we show using the non-hydrolyzable NAD+ analog benzamide adenine dinucleotide (BAD) that PARP-1 autoinhibition results from a selective block on NAD+ binding. Following DNA damage detection, BAD binding to the catalytic domain leads to changes in PARP-1 dynamics at distant DNA-binding surfaces, resulting in increased affinity for DNA damage, and providing direct evidence of reverse allostery. Our findings reveal a two-step mechanism to activate and to then stabilize PARP-1 on a DNA break, indicate that PARP-1 allostery influences persistence on DNA damage, and have important implications for PARP inhibitors that engage the NAD+ binding site.Poly(ADP-ribose) polymerases (PARPs) catalyse ADP-ribose posttranslational modifications using NAD+ as a substrate. Here, the authors present the crystal structure of PARP-1 bound to the non-hydrolyzable NAD+ analog BAD and provide insights into the mechanism of PARP-1 allosteric regulation.

[1]  L. Lehtiö,et al.  Characterization of the DNA dependent activation of human ARTD2/PARP2 , 2016, Scientific Reports.

[2]  D. Eisenberg,et al.  Unusual conformation of nicotinamide adenine dinucleotide (NAD) bound to diphtheria toxin: A comparison with NAD bound to the oxidoreductase enzymes , 1997, Protein science : a publication of the Protein Society.

[3]  G. Schulz,et al.  Inhibitor and NAD+ binding to poly(ADP-ribose) polymerase as derived from crystal structures and homology modeling. , 1998, Biochemistry.

[4]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[5]  T. Ellenberger,et al.  The rise and fall of poly(ADP-ribose): An enzymatic perspective. , 2015, DNA Repair.

[6]  J. Pascal,et al.  PARP-2 domain requirements for DNA damage-dependent activation and localization to sites of DNA damage , 2015, Nucleic acids research.

[7]  J. Pascal,et al.  A Third Zinc-binding Domain of Human Poly(ADP-ribose) Polymerase-1 Coordinates DNA-dependent Enzyme Activation* , 2008, Journal of Biological Chemistry.

[8]  J. Pascal,et al.  Structural Basis of Detection and Signaling of DNA Single-Strand Breaks by Human PARP-1 , 2015, Molecular cell.

[9]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[10]  L. Pearl,et al.  PARP3 is a sensor of nicked nucleosomes and monoribosylates histone H2BGlu2 , 2016, Nature Communications.

[11]  N. Pannu,et al.  REFMAC5 for the refinement of macromolecular crystal structures , 2011, Acta crystallographica. Section D, Biological crystallography.

[12]  Jamin D Steffen,et al.  PARP-1 Activation Requires Local Unfolding of an Autoinhibitory Domain. , 2015, Molecular cell.

[13]  L. Lehtiö,et al.  Evaluation and Structural Basis for the Inhibition of Tankyrases by PARP Inhibitors. , 2014, ACS medicinal chemistry letters.

[14]  J. Pascal,et al.  The Zn3 Domain of Human Poly(ADP-ribose) Polymerase-1 (PARP-1) Functions in Both DNA-dependent Poly(ADP-ribose) Synthesis Activity and Chromatin Compaction* , 2010, The Journal of Biological Chemistry.

[15]  Sejal Vyas,et al.  New PARP targets for cancer therapy , 2014, Nature Reviews Cancer.

[16]  S. Englander Hydrogen exchange and mass spectrometry: A historical perspective , 2006, Journal of the American Society for Mass Spectrometry.

[17]  J. Pascal,et al.  Structural Basis for DNA Damage–Dependent Poly(ADP-ribosyl)ation by Human PARP-1 , 2012, Science.

[18]  J. Pascal,et al.  Purification of human PARP-1 and PARP-1 domains from Escherichia coli for structural and biochemical analysis. , 2011, Methods in molecular biology.

[19]  S. Asli Özgün-Koca,et al.  A Historical Perspective from "a" to "c" , 2010 .

[20]  Ziying Liu,et al.  PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes , 2017, Genes & development.

[21]  J. Pascal,et al.  Crystal Structures of Poly(ADP-ribose) Polymerase-1 (PARP-1) Zinc Fingers Bound to DNA , 2011, The Journal of Biological Chemistry.

[22]  R. Armen,et al.  Structural Implications for Selective Targeting of PARPs , 2013, Front. Oncol..

[23]  G. Poirier,et al.  Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. , 1999, The Biochemical journal.

[24]  D Eisenberg,et al.  Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide. , 1997, Advances in experimental medicine and biology.

[25]  P. K. Glasoe,et al.  USE OF GLASS ELECTRODES TO MEASURE ACIDITIES IN DEUTERIUM OXIDE1,2 , 1960 .

[26]  J. Pascal,et al.  Purification of DNA Damage-Dependent PARPs from E. coli for Structural and Biochemical Analysis. , 2017, Methods in molecular biology.

[27]  Randy J. Read,et al.  Overview of the CCP4 suite and current developments , 2011, Acta crystallographica. Section D, Biological crystallography.

[28]  Eric F. Johnson,et al.  Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1). , 2009, Bioorganic & medicinal chemistry letters.

[29]  Leland Mayne,et al.  ExMS: Data Analysis for HX-MS Experiments , 2011, Journal of the American Society for Mass Spectrometry.

[30]  Y. Pommier,et al.  Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. , 2012, Cancer research.

[31]  J. Pinkner,et al.  Structural basis of Streptococcus pyogenes immunity to its NAD+ glycohydrolase toxin. , 2011, Structure.

[32]  F. Jiang,et al.  Synthesis of carba-NAD and the structures of its ternary complexes with SIRT3 and SIRT5. , 2012, The Journal of organic chemistry.

[33]  A. J. Shaka,et al.  Water Suppression That Works. Excitation Sculpting Using Arbitrary Wave-Forms and Pulsed-Field Gradients , 1995 .

[34]  J. Pascal,et al.  PARP-2 and PARP-3 are selectively activated by 5′ phosphorylated DNA breaks through an allosteric regulatory mechanism shared with PARP-1 , 2014, Nucleic acids research.

[35]  A. Zatorski,et al.  Chemical synthesis of benzamide adenine dinucleotide: inhibition of inosine monophosphate dehydrogenase (types I and II). , 1996, Journal of medicinal chemistry.

[36]  A. Schnapp,et al.  Functional characterization of the poly(ADP-ribose) polymerase activity of tankyrase 1, a potential regulator of telomere length. , 2002, Journal of molecular biology.

[37]  A. R. Merrill,et al.  The nature and character of the transition state for the ADP‐ribosyltransferase reaction , 2008, EMBO reports.

[38]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[39]  G. Schulz,et al.  The mechanism of the elongation and branching reaction of poly(ADP-ribose) polymerase as derived from crystal structures and mutagenesis. , 1998, Journal of molecular biology.